Both in Pharmaceuticals
Omeros vs UroGen Pharma
Over the past year OMER returned +144.2% and URGN returned +33.2%; their daily moves had a correlation of 0.12.
OMER +144.2% URGN +33.2%Growth of $1, one year, split-adjusted
| Metric | OMER | URGN |
|---|---|---|
| Price | $17.07 | $25.73 |
| Market cap | $1.24B | $1.26B |
| Today | −6.11% | −10.47% |
| 1 month | −9.0% | −36.8% |
| 6 months | +16.6% | −3.2% |
| Year to date | −0.6% | +9.9% |
| 1 year | +153.6% | +29.9% |
| Revenue growth (YoY) | — | +199.2% |
| Gross margin | 97.2% | 90.9% |
| Net margin | 46.4% | −19.8% |
| P/E (TTM) | 9.9× | — |
| Price / sales | 32.2× | 6.7× |
| Net cash | $58.7M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 77.9% | 57.8% |
| Short % of float | 17.8% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).